Optimizing TPD-based oncology drug development: the critical role of PDR distribution in POI-positive cancer cells
Saved in:
| Main Authors: | Xinyi Tao, Li Zou, Wenxin Fang, Ruolan Zhang, Jianhui Liang, Yan Wang, Lei Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-04-01
|
| Series: | Acta Pharmaceutica Sinica B |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383525000899 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A multi-omic single-cell landscape reveals transcription and epigenetic regulatory features of t(8;21) AML
by: Xue-Ping Li, et al.
Published: (2025-07-01) -
Immune-related hub genes and their role in psoriasis pathogenesis
by: Tingting Yin, et al.
Published: (2025-05-01) -
Single-cell sequencing combined with machine learning to identify glioma biomarkers and therapeutic targets
by: Yu Yan, et al.
Published: (2025-07-01) -
Comprehensive analysis of the LINC01122/TPD52 axis as a predictive biomarker in prostate adenocarcinoma
by: Zhi Shang, et al.
Published: (2025-05-01) -
Identification of sepsis biomarkers through glutamine metabolism-mediated immune regulation: a comprehensive analysis employing mendelian randomization, multi-omics integration, and machine learning
by: Zhuang’e Shi, et al.
Published: (2025-08-01)